Vomikind Injection
Marketer
Mankind Pharma Ltd
Salt Composition
Ondansetron (2mg)
Overview Vomikind Injection
Nausea and vomiting associated with various medical conditions, including post-surgical recovery, cancer treatments (chemotherapy and radiotherapy), and gastrointestinal distress, may be managed with Emeseject, an antiemetic injection. Emeseject is not a panacea for all cancer treatment side effects; it specifically targets nausea and vomiting. Administered under medical supervision, Emeseject can be used independently or in conjunction with other therapies. Dosage is determined by your physician based on your individual needs and should continue as directed until your doctor deems it safe to discontinue. Oral medication may then be prescribed. Common, generally transient, side effects include injection site discomfort, headache, and constipation. Persistent or bothersome side effects necessitate consultation with your doctor, who can provide strategies for mitigation. Prior to initiating Emeseject therapy, inform your physician of any pre-existing conditions, such as cardiac or hepatic dysfunction, or gastrointestinal obstructions. Furthermore, disclose all current medications, particularly those for epilepsy, cardiovascular disease, cancer, or depression, as interactions may occur. Pregnant or breastfeeding individuals should seek medical guidance before using this medication.
Uses of Vomikind Injection
Managing Nausea and Vomiting
Major Benefits of Vomikind Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Vomikind Injection:
- Injection site pain
- Constipation
- Diarrhea
- Fatigue
- Headache
How to use Vomikind Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Vomikind Injection works:
Vomikind Injection is an anti-nausea medication. Its mechanism of action involves inhibiting the effects of serotonin, a neurotransmitter in the brain that can trigger nausea and vomiting, particularly in patients undergoing chemotherapy or recovering from surgery.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of Vomikind Injection and alcohol presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The use of Vomikind Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or absent harmful effects on fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Employing Vomikind Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Vomikind Injection.
KidneySAFE IF PRESCRIBED
Vomikind Injection poses no known safety concerns for individuals with kidney impairment; dosage modification isn't necessary. Nevertheless, disclosure of pre-existing kidney disease to your physician is advisable. Data on usage exceeding 24 hours is currently limited.
LiverCONSULT YOUR DOCTOR
Data regarding Vomikind Injection use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Vomikind Injection :
Should you forget a Vomikind Injection dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vomikind Injection
| Label | Value |
|---|---|
| Chemical Category | Carbazole-based compound |
| Developing Good Habits | No. |
| Treatment Category | Gastrointestinal system |
| Action Class | 5-HT3 receptor blockers |





